Status:
TERMINATED
Optimal Dose of Proton Pump Inhibitors Following an Upper Gastrointestinal Bleed
Lead Sponsor:
University of Missouri-Columbia
Conditions:
Upper Gastrointestinal Bleed
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Despite recommendations from clinical practice guidelines to discharge patients from the hospital on once daily proton pump inhibitors after acute management of UGIB, clinical practice is to use twice...
Detailed Description
There are few clinical practice guidelines for the management of a non-variceal, upper gastrointestinal bleed (UGIB). The 2012 guidelines released by the American College of Gastroenterology (ACG) ind...
Eligibility Criteria
Inclusion
- Adult, 18 years and older; Upper GI bleed confirmed by endoscopy
Exclusion
- Intensive Care Unit admission, Emergency endoscopic intervention required to control bleeding, Malignant appearing ulcers as determined by endoscopy, Previous documented treatment with twice daily PPI for other indication, Receiving twice daily PPI therapy prior to admission
Key Trial Info
Start Date :
October 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 17 2015
Estimated Enrollment :
3 Patients enrolled
Trial Details
Trial ID
NCT02235311
Start Date
October 1 2014
End Date
August 17 2015
Last Update
July 31 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital
Columbia, Missouri, United States, 65112